Want to join the conversation?
$ABBV 2Q15 Q&A: Holford of Jefferies asked about VIEKIRA contracts in US. Mike, Chief Scientific Officer explains that the VIEKERA contracting has not changed a lot in US. We have a number of exclusive contracts that were coming on line. The rest of the growth will be around driving these incremental contracts and also additional share gains.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.